Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Senores Pharmaceuticals has informed that, post announcement of Un-audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025, the Company will hold the earnings conference call for Q1FY26 on Thursday, July 24, 2025, at 03:30 PM (IST). The details of the aforesaid earnings conference call are annexed. The audio recording and transcript of the aforesaid call will be subsequently published on the website of the Company and will be intimated accordingly.
The above information is a part of company’s filings submitted to BSE.
